Effect of Dialysis on Erythropoietin and some Hematological Parameters in Patients with Chronic Renal Failure

Zhian Sh. Hayder; Jamal M. Aziz; Mohamad Salih Jaff

doi:10.15218/zjms.2009.014

Authors

Zhian Sh. Hayder Salahaddin University- Erbil, College of Science. Biology Department.
Jamal M. Aziz Salahaddin University- Erbil, College of Science. Biology Department.
Mohamad Salih Jaff Hawler Medical University, College of Medicine. Pathology Department.

DOI:

https://doi.org/10.15218/zjms.2009.014

Keywords:

Dialysis, Erythropoietin, Chronic renal failure.

Abstract

Background and objective: A prospective study was carried out for estimation the concentration of the erythropoietin hormone and its effects on some hematological parameters in chronic renal failure patients despite medical treatment. The object of the study was to evaluate the available evidences which support the relationship between anemia and adverse outcomes in chronic renal failure patients, to estimate the erythropoietin concentration of plasma in chronic renal failure patients and to examine the relationship between the anemia and erythropoietin concentration in patients with chronic kidney disease.

Methods: One hundred and eleven (111) patients with CRF on dialysis in the Dialysis and Kidney Disease Center in Hawler Teaching Hospital and (40) control groups were studied. Haematological parameters: were performed by conventional manual methods. The quantitative measurement of erythropoietin concentration in serum was done by using the Erythropoietin ELISA kit (IBL Immuno Biological Laboratories Hamburg Erythropoietin Kit, German).

Results: Hemoglobin, red blood cells, packed cell volume, and mean corpuscular hemoglobin were significantly decreased (P<0.001) in all age groups of Chronic renal failure patients, while, erythrocyte sedimentation rate and mean corpuscular volume (MCV) were increased significantly (P<0.001). Total white blood cells were decreased significantly (P<0.01) at the ages (40-60, >60) years groups, while not significantly decreased at the ages (<20, 20-40) years. Plasma erythropoietin was decreased significantly at the level (P<0.001) in chronic renal failure patients.

Conclusion: Anemia is a common and often an early complication of chronic renal diseases and decreased renal production of erythropoietin is the major cause of anemia in these patients.

Metrics

Metrics Loading ...

References

Levy, J., Morgan, J. and Brown, E. Oxford handbook of Dialysis, 2nd ed. 2004. Oxford University Press.

Agarwal, S.K., Saxena, S., Nandy, M. and Gupta, S. Recombinant Human Erythropoietin in the Management of Anemia in Chronic Kidney Disease Patients. An Indian Multicentre Experience JIACM. 2006, 7(3); 193-198.

Eschbach, J.W.The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin. Kidney lnt. 1989, 35:134-48.

Spivak, J.L., Bell, R.W., Ness, P. M., Quesenberry, P.J. and Wiernik, P. H. The Year Book of Hematology .1987. Year Book Medical Publishers Inc.

Pereira, B.J., Sayegh, M.H. and Blake, P.G. Chronic kidney diseases, Dialysis and Transplantation, 2nd edition. Elsevier Saunders. Hematology. 2005. MASS PUBLISHING Co. Hill Companies Inc.

Kurtz, A. and Eckardt, K.U. Erythropoietin production in chronic renal disease before and after renal transplantation. Contrib Nephrol. 1990. 87:15-25.

Frandrey, J. and Bunn, H.F. In vivo and in vitro regulation of erythropoietin mRNA: measurement by competitive polymerase chain reaction. Blood. 1993, 81:617–623.

Kacsoh . B. Endocrine Physiology. 2000. McGraw-Hill companies, Inc.

Masuda, S., Okano, M., Yamagishi, K., Nagao, M., Ueda, M., Sasaki, R. A. Novel site of erythropoietin production. J Biol Chem. 1994, 269: 19488–19493.

Kasper, D.L., Braunwald, E., Fauci, A.S., Hauser, S.L., Longo, D.L. and Jameson, J.L. Principles of Internal Medicine, 16th ed, Volume I. 2005. McGraw-Hill Companies Inc.

Marsden, J.T., Sherwood, R.A. and Peters T.J. Evaluation of six erythropoietin kits. Department of Clinical Biochemistry. Kings College School of Medicine and Dentistry, London SE 5 9 PJ UK. Ann Clin Biochem. 1999, 36: 380-387.

Masaki, Y., Oka N., Furuya, H., Ohguni, S., Takagi, C. and Sato, T..Clinical use of serum erythropoietin determination by the recombogen EPO RIA kit. Medicine. 1992, 29:70I-707.

Chandra, M., Clemons, G.K. and McVicar, M.I. Relation of serum erythropoietin levels to renal excretory function: evidence for lowered set point for erythropoietin production in chronic renal failure. J Pediatr. 1988, 113:1015-21.

Bovy, C., Tsobo, C., Crapanzano, L., Rorive, G., Beguin, Y. and Albert A.. Factors determining the percentage of hypochromic red blood cells in hemodialysis patients. Kidney Int. 1999, 56: 1113-9.

Shaheen F.A. and Souqiyyeh M.Z. Guidelines for the Treatment of Anemia in Chronic Renal Failure Patients in Saudi Arabia. 2005, 16(3):1319-2442.

McGonigle, R. J., Wallin, J. D., and Shadduck, R. K., (1984). Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. Kidney Int. 25: 437.

Goodnough, L.T., Skikne, B. and Brugnara, C. Erythropoietin, iron, and erythropoiesis. Blood. 2000, 96:823-833.

Snyder, J.J., Foley,R.N., Gilbertson, D.T., Vonesh, E.F. and Collins, A.J. Hemoglobin Levels and Erythropoietin Doses in Hemodialysis and Peritoneal Dialysis Patients in the United States. J AM Soc Nephrol.2004, 15:174-179.

Wallner, S. F., and Vautrin, R. M. Evidence that inhibition of erythropoiesis is important in the anemia of chronic renal failure. J. Lab. Clin. Med. 1981 97: 170.

Drueke, T. Hyporesponsiveness to recombinant human erythropoietin. Nephrol Dial Transplant. 2001, 16[Suppl 7]: 25-28.

Stenvinkel, P. The role of inflammation in the anaemia of end stage renal disease. Nephrol Dial Transplant. 2001, 16[Suppl 7]: 36-40.

Ganz, T. Hepcidin, a key regulator of iron metabolism and mediator for anemia of inflammation. Blood. 2003, 102:783-788.

Kendall, R.G., Jeffries R, Cavill, and Norfolk, D.R.Relationship between endogenous erythropoietin levels, reticulocyte count and reticulocyte RNA distribution, a study of anemic patients with and without renal failure. Annals of the New York Academy of Sciences. 1994, (718): 353-355.

Fisher, J.W. Erythropoietin: Physiology and pharmacology update. Exp Biol Med (Maywood). 2003, 228:1-14.

Mittman, N., Sreedhara, R., Mushnick, R., Chattopadhyay, J., Zelmanovic, D. and Vaseghi M. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO. Am J Kidney Dis. 1997, 30:912-22.

Brugnara, C. Reticulocyte cellular indices: a new approach in the diagnosis of anemias and monitoring of erythropoietic function. Crit Rev Chin Lab Sci. 2000, 37:93-130.